Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
Type:
Grant
Filed:
November 20, 2019
Date of Patent:
October 6, 2020
Assignees:
Hugel Inc., Small Lab Co., Ltd.
Inventors:
Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon, Juhyung Shin
Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
Type:
Application
Filed:
November 20, 2019
Publication date:
April 23, 2020
Applicants:
Hugel Inc., Small Lab Co., Ltd.
Inventors:
Kyeong Yeop MOON, Chang Jin LEE, Dae Gun KIM, Dong Hoon OH, Do Hyun KANG, Woo Ran LEE, Jeong Gyu LEE, Jun Jin YOON, Juhyung SHIN
Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
Type:
Grant
Filed:
October 12, 2017
Date of Patent:
January 7, 2020
Assignees:
Hugel, Inc., Small Lab Co., Ltd.
Inventors:
Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon
Abstract: Provided are micro-needles and a micro-needle patch for transdermal delivery of a pharmaceutical, medical, or cosmetic substance. The micro-needle may include a biocompatible matrix having a micro-needle-like shape; and porous particles provided at at least a portion of a surface or the interior of the biocompatible matrix.